{"id":165489,"date":"2018-10-23T12:48:08","date_gmt":"2018-10-23T12:48:08","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=165489"},"modified":"2018-10-23T12:48:08","modified_gmt":"2018-10-23T12:48:08","slug":"incotro-se-indreapta-piata-farmaceutica-din-romania-cum-ar-putea-avea-romanii-acces-la-tratamente-noi-si-mai-ieftine","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=165489","title":{"rendered":"\u00cencotro se \u00eendreapt\u0103 pia\u0163a farmaceutic\u0103 din Rom\u00e2nia. Cum ar putea avea rom\u00e2nii acces la tratamente noi \u015fi mai ieftine"},"content":{"rendered":"<p>\nChristian Rodseth,&nbsp;Managing Director Janssen Companie Farmaceutica a&nbsp;Johnson &#038; Johnson Rom\u00e2nia, spune c\u0103 pia\u0163a farmaceutic\u0103 din Rom\u00e2nia se \u00eendreapt\u0103 c\u0103tre o dinamic\u0103 echilibrat\u0103 \u015fi c\u0103 a remarcat un progres constant raportat la cadrul \u00een care produc\u0103torii \u00ee\u015fi desf\u0103\u015foar\u0103 activitatea. Observ\u0103 totu\u015fi c\u0103 \u00een anumite zone pot fi aduse \u00eembun\u0103t\u0103\u0163iri pentru a ajunge la acel nivel de predictibilitate \u015fi sustenabilitate pentru toate p\u0103r\u0163ile implicate \u2013 pacien\u0163i, autorit\u0103\u0163i \u015fi industria farmaceutic\u0103 deopotriv\u0103.<\/p>\n<p>\nUna dintre zonele de interes al companiei este cea a parteneriatelor public-private, pe care reprezentan\u0163ii Janssen o consider\u0103 o solu\u0163ie pentru \u00eembun\u0103t\u0103\u0163irea accesului la tratament al pacien\u0163ilor rom\u00e2ni diagnostica\u0163i cu tuberculoz\u0103, spre exemplu.<\/p>\n<p>\n\u201eAngajamentul nostru este s\u0103 identific\u0103m solu\u0163ii sustenabile al\u0103turi de autorit\u0103\u0163i pentru a adresa eventuale obstacole privind accesibilitatea pacien\u0163ilor rom\u00e2ni la medicamente inovatoare. Este necesar s\u0103 cooper\u0103m pentru a face trecerea c\u0103tre un sistem de s\u0103n\u0103tate care pune pacientul \u00een centrul s\u0103u \u015fi care este dezvoltat pe baza m\u0103sur\u0103rii rezultatelor ob\u0163inute. Acest lucru poate fi realizat prin adresarea eventualelor zone ineficiente din sistem \u015fi prin recunoa\u015fterea rezultatelor \u00eembun\u0103t\u0103\u0163ite pentru pacien\u0163i, \u00een ansamblu prin cost-eficien\u0163\u0103\u201d, argumenteaz\u0103 Rodseth.<\/p>\n<p>\nLa fel de importante consider\u0103 c\u0103 sunt \u015fi schemele de acces facilitat, care permit produc\u0103torilor s\u0103 adreseze eventualele semne de \u00eentrebare pe care le pot avea autorit\u0103\u0163ile statului, care pl\u0103tesc pentru medicamente, cu privire la valoarea \u015fi accesibilitatea medicamentelor noi.<\/p>\n<p>\n\u201eAceste mecanisme sunt o solu\u0163ie \u00abwin-win\u00bb deoarece permit un acces mai larg sau timpuriu la medicamentele noi, \u00een paralel cu controlul costurilor; genereaz\u0103 scheme flexibile de pre\u0163 care sunt specifice sistemelor de compensare din \u0163\u0103ri \u015fi reflect\u0103 nivelul local de accesibilitate, precum \u015fi prevalen\u0163a afec\u0163iunilor.\u201d El spune c\u0103, recent, au avut loc o serie de discu\u0163ii importante \u00eentre autorit\u0103\u0163i \u015fi industrie despre modul \u00een care poate fi crescut bugetul alocat medicamentelor, fapt care \u201edemonstreaz\u0103 c\u0103 se pot dezvolta solu\u0163ii \u00eentr-un mediu al dialogului \u00een care sunt implicate toate p\u0103r\u0163ile\u201d.<\/p>\n<p>\nO provocare pe care Christian Rodseth o remarc\u0103 la nivelul industriei este taxa claw-back, introdus\u0103 ini\u0163ial \u00een 2009 ca m\u0103sur\u0103 temporar\u0103. \u201eTrebuie s\u0103 vedem cum putem ajunge al\u0103turi de autorit\u0103\u0163i la o versiune mai predictibil\u0103 \u015fi mai transparent\u0103 a acesteia. Propunerea ARPIM (Asocia\u0163ia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u0163ionali de Medicamente \u2013 n. red.) pe termen scurt pentru acest an este fixarea taxei claw-back la 15% pentru medicamentele originale.<\/p>\n<div>\n&nbsp;<\/div>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Christian Rodseth,&nbsp;Managing Director Janssen Companie Farmaceutica a&nbsp;Johnson &#038; Johnson Rom\u00e2nia, spune c\u0103 pia\u0163a farmaceutic\u0103 din Rom\u00e2nia se \u00eendreapt\u0103 c\u0103tre o dinamic\u0103 echilibrat\u0103 \u015fi c\u0103 a remarcat un progres constant raportat la cadrul \u00een care produc\u0103torii \u00ee\u015fi desf\u0103\u015foar\u0103 activitatea. Observ\u0103 totu\u015fi c\u0103 \u00een anumite zone pot fi aduse \u00eembun\u0103t\u0103\u0163iri pentru a ajunge la acel nivel de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[238,332,33525,10313,14610,272,201,342,10565,246,7442,8337,11056,474,265,323,408,19981,60,36921,8018,16978,245,7147,44761,8690,9789,518,173,98,205,32963,7287,12923],"class_list":["post-165489","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-acces","tag-activitate","tag-afectiuni","tag-autoritati","tag-cancer","tag-companie","tag-companii","tag-continuare","tag-contributie","tag-crestere","tag-dezvoltare","tag-evolutie","tag-financiar","tag-industrie","tag-inovatie","tag-medicamente","tag-pacienti","tag-perioada","tag-piata","tag-piata-farmaceutica","tag-planuri","tag-portofoliu","tag-prezenta","tag-producatori","tag-prostata","tag-public","tag-reprezentanti","tag-rezultate","tag-romani","tag-romania","tag-sanatate","tag-scheme","tag-sistem","tag-tratament"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/165489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=165489"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/165489\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=165489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=165489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=165489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}